Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma
新型组蛋白去乙酰化酶抑制剂 bisthianostat 治疗复发或难治性多发性骨髓瘤的药效学、药代动力学及 1a 期研究
期刊:Acta Pharmacologica Sinica
影响因子:6.9
doi:10.1038/s41401-021-00728-y
Yu-Bo Zhou #, Yang-Ming Zhang #, Hong-Hui Huang #, Li-Jing Shen, Xiao-Feng Han, Xiao-Bei Hu, Song-da Yu, An-Hui Gao, Li Sheng, Ming-Bo Su, Xiao-Li Wei, Yue Zhang, Yi-Fan Zhang, Zhi-Wei Gao, Xiao-Yan Chen, Fa-Jun Nan, Jia Li, Jian Hou1
